These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25088832)

  • 1. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
    Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
    Med Phys; 2012 Sep; 39(9):5732-9. PubMed ID: 22957638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound histogram assessment of parotid gland injury following head-and-neck radiotherapy: a feasibility study.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
    Ultrasound Med Biol; 2012 Sep; 38(9):1514-21. PubMed ID: 22766120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
    Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
    Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.
    Belli ML; Scalco E; Sanguineti G; Fiorino C; Broggi S; Dinapoli N; Ricchetti F; Valentini V; Rizzo G; Cattaneo GM
    Strahlenther Onkol; 2014 Oct; 190(11):1001-7. PubMed ID: 24756139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: a feasibility study of late toxicity.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Wu N; Wang Y; Bruner DW; Curran WJ; Liu T
    Med Phys; 2014 Feb; 41(2):022903. PubMed ID: 24506650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
    Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
    Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic imaging biomarkers of postradiotherapy xerostomia.
    Cannon B; Schwartz DL; Dong L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of parotid function with uncomplicated conformal radiotherapy.
    Maes A; Weltens C; Flamen P; Lambin P; Bogaerts R; Liu X; Baetens J; Hermans R; Van den Bogaert W
    Radiother Oncol; 2002 May; 63(2):203-11. PubMed ID: 12063010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
    van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
    Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and volume impact on radiation-induced xerostomia.
    Marmiroli L; Salvi G; Caiazza A; Di Rienzo L; Massaccesi M; Murino P; Macchia G
    Rays; 2005; 30(2):145-8. PubMed ID: 16294907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.
    Wu H; Chen X; Yang X; Tao Y; Xia Y; Deng X; Zheng C; Robbins J; Schultz C; Li XA
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1308-1318. PubMed ID: 29891201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
    Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence.
    Marzi S; Pinnarò P; D'Alessio D; Strigari L; Bruzzaniti V; Giordano C; Giovinazzo G; Marucci L
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):e54-62. PubMed ID: 22138192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
    Rosen BS; Hawkins PG; Polan DF; Balter JM; Brock KK; Kamp JD; Lockhart CM; Eisbruch A; Mierzwa ML; Ten Haken RK; El Naqa I
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1319-1329. PubMed ID: 30003997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.